News and Articles

Among the numerous microengineered Organ-on-a-Chip (Organ Chip) models developed at Harvard’s Wyss Institute, the Liver…

-Sigilon Therapeutics announced today that it will present data at the American Society of Hematology Annual…

Current treatment regimens for Mycobacterium tuberculosis (Mtb), the causative agent of tuberculosis, are long, complex, and hard…

A new study from the laboratory of Frederick Alt, PhD, of the Program in Cellular and Molecular Medicine (PCMM) at…

MIT engineers have shown that they can enhance the performance of drug-delivery nanoparticles by controlling…

As people age, they tend to develop diseases such as heart failure, kidney failure, diabetes,…

Researchers from MIT will be collaborating with colleagues at the University of Colorado at Boulder…